Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
22.51
-0.36 (-1.57%)
Jan 23, 2025, 12:22 PM EST - Market open
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 167 employees as of December 31, 2023. The number of employees increased by 85 or 103.66% compared to the previous year.
Employees
167
Change (1Y)
85
Growth (1Y)
103.66%
Revenue / Employee
$2,757,377
Profits / Employee
$855,072
Market Cap
2.68B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CPRX News
- 4 hours ago - Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies - GlobeNewsWire
- 2 days ago - Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan - GlobeNewsWire
- 10 days ago - Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE - Seeking Alpha
- 14 days ago - Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals - GlobeNewsWire
- 5 weeks ago - Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work - GlobeNewsWire